FLT3 and acute myeloid leukemia: Mutations in the FMS-related tyrosine kinase 3 (FLT3) gene represent one of the most frequent and clinically challenging event in Acute Myeloid Leukemia (AML), occurring in the 25% of newly diagnosed cases [1].